A single shot of self-amplifying RNA can repair tissue damage from a heart attack, new research in pigs and mice shows. It can take weeks or months to recover from a heart attack, but the new study ...

Scientists have developed a new therapy designed to repair cardiac damage after a heart attack. The study, led by researchers at Columbia University and published in the journal Nature Biomedical ...

In people with mild to moderate hypertension taken off antihypertensive treatment, quarterly and biannual injections of novel RNA silencer zilebesiran showed promise for safely reducing systolic blood ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A single self‑amplifying RNA injection that boosts a heart‑healing peptide cut scarring and ...

Overall survival (OS) and pathologic response rate from a phase II clinical trial of neoadjuvant GVAX pancreas vaccine (with cyclophosphamide) in combination with nivolumab and stereotactic body ...

Zilebesiran, an interfering RNA, administered every 3-6 months lowers blood pressure in patients with mild to moderate hypertension. For patients with mild to moderate hypertension, a single injection ...

In this Peek Behind the Paper, we learn more about a recently published paper by Joaquin Abugattas-Nuñez Del Prado (Leiden University, The Netherlands; Universidad Peruana Cayetano Heredia, Lima, Perú ...